Latest Conference Articles

Kristin Wipfler, PhD: Issues Accessing Methotrexate in the Post-Roe vs Wade Era

November 12th 2022

American College of Rheumatology Convergence (ACR)

Wipfler emphasized that most of the delays have been associated with pharmacies needing to confirm the purpose of the prescription with the provider.

Telitacicept Improves SELENA-SLEDAI Scores for SLE Patients

November 12th 2022

American College of Rheumatology Convergence (ACR)

A significantly larger portion of patients in the telitacicept 160 mg achieved SR14 response compared to the placebo group.

Early TNF Inhibitor Initiation in Ankylosing Spondylitis Linked to Increase Cardiovascular Risk

November 12th 2022

American College of Rheumatology Convergence (ACR)

An analysis of more than 17,000 Veterans suggests early initiation of TNF inhibitor therapy in patients with ankylosing spondylitis was associated with an increased risk of incident cardiovascular disease and major adverse cardiovascular events.

Kristin Wipfler, PhD: Has Overturning Roe vs Wade Affected Access to Methotrexate?

November 11th 2022

American College of Rheumatology Convergence (ACR)

“We imagine that the rate of problems [accessing methotrexate] is going to be much higher in higher-risk populations," Wipfler explained.

Glucocorticoid Use Results in BMD Loss for Women with Rheumatic Disease

November 11th 2022

American College of Rheumatology Convergence (ACR)

Anti-osteoporotic treatment resulted in increased BMD to a greater extent in patients treated with less than 5 mg per day of prednisone.

Cuoghi Edens, MD: Fertility and Assisted Reproductive Technologies in Rheumatic Disease

November 11th 2022

American College of Rheumatology Convergence (ACR)

Cuoghi Camille Edens, MD, discusses her upcoming ACR presentation, “Fertility and the Use of Assisted Reproductive Technologies: Perceptions, Thoughts and Experiences of Men and Women with Rheumatic Disease.”

Shilpa Venkatachalam, PhD, MPH: Reducing Vaccine Hesitancy in Patients with Autoimmune Diseases

November 10th 2022

American College of Rheumatology Convergence (ACR)

Although patients with autoimmune diseases are more likely to develop severe vaccine-preventable infections, vaccine uptake remains relatively low in this patient population.

Shilpa Venkatachalam, PhD: Prioritizing Patient-Centered Research in Autoimmune Diseases

November 10th 2022

American College of Rheumatology Convergence (ACR)

Investigators believe it is important to understand the patient's perspective regarding vaccine concerns and combining that perspective with stakeholders to prioritize topics for future research.

ACR 22 Convergence Preview, with Zsuzsanna McMahan, MD

November 7th 2022

American College of Rheumatology Convergence (ACR)

In this episode of the Overdrive podcast, Dr. McMahan sits down to discuss the upcoming ACR 22 Convergence meeting and what attendees might be able to expect from the perspective of an ACR Annual Meeting Planning Committee member.

John Cush, MD: How Early is Too Early to Diagnose and Treat Rheumatoid Arthritis?

October 21st 2022

Congress of Clinical Rheumatology (CCR)

John Cush, MD, discusses his presentation “Rheumatoid Arthritis: How Early is Too Early to Diagnose and Treat?”